International Clinical Trial: A prospective, observational, single arm clinical study to explore the efficacy and safety of concurrent chemoradiotherapy with cisplatin / carboplatin combined with Iparomlimab and Tuvonralimab in the adjuvant treatment of postoperative cervical cancer patients with high-risk factors

Geneva, Jan. 12 -- International Clinical Trials Registry received information related to the study (ChiCTR2500115098) titled 'A prospective, observational, single arm clinical study to explore the efficacy and safety of concurrent chemoradiotherapy with cisplatin / carboplatin combined with Iparomlimab and Tuvonralimab in the adjuvant treatment of postoperative cervical cancer patients with high-risk factors' on Dec. 22, 2025.

Study Type: Interventional study

Study Design: Single arm

Primary Sponsor: Harbin Medical University Cancer Hospital

Condition: Postoperative cervical cancer with high-risk factors

Recruitment Status: Not Recruiting

Phase: 4

Date of First Enrollment: 2025-12-23

Target Sample Size: Test group:60;

Co...